Supernus Pharmaceuticals, Inc. logo SUPN - Supernus Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 9
HOLD 5
SELL 0
STRONG
SELL 0
| PRICE TARGET: $60.00 DETAILS
HIGH: $65.00
LOW: $55.00
MEDIAN: $60.00
CONSENSUS: $60.00
UPSIDE: 24.46%

Profitability Ratios

Ratio Value
GP Margin 89.6%
EBIT Margin -6.8%
EBITDA Margin 5.9%
Operating Margin -5.1%
Pretax Margin -6.8%
Cont. Ops Margin -5.4%
Net Margin -5.4%
Bottom Line Margin -5.4%

Liquidity Ratios

Ratio Value
Current Ratio 1.90
Quick Ratio 1.66
Solvency Ratio 0.136
Cash Ratio 0.38

Valuation Ratios

Ratio Value
Price/Earnings
-72.78
Hist. avg: 21.6
Peers avg: 23.9
PEG Ratio 0.48
Forward PEG 0.48
Price/Book 2.64
Price/Sales 3.90
Price/FCF 61.00
Price/Op Cash Flow 59.28

Debt Ratios

Ratio Value
Debt/Assets 0.0282
Debt/Equity 0.0386
Debt/Capital 0.0372
Long-Term Debt/Capital 0.0000
Financial Leverage 1.37

Cash Flow Ratios

Ratio Value
Working Capital Turnover 2.06
Operating Cash Flow Ratio 0.140
Operating Cash Flow/Sales 6.6%
Free Cash Flow/Operating Cash Flow 97.2%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.00
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 1.16
Capital Expenditure Coverage 35.37
Dividend + Capital Expenditure Coverage 35.37

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 12.74
EPS -0.683
Debt/Share 0.7259
Cash/Share 5.47
Book Value/Share 18.81
Tangible BV/Share 6.51
Equity/Share 18.81
Operating Cash Flow/Share 0.838
Capital Expenditure/Share 0.024
FCF/Share 0.815

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.786
Earnings Before Tax/EBIT 1.330
Price/Fair Value 2.64
Debt/Market Cap 0.0000
Effective Tax Rate 21.4%
Enterprise Value Multiple 63.91